Imperial College
3 inventions
IHC
IF
IP
WB
Antigen/Gene or Protein Targets: Integrin a2bß3 (CD41 & CD61)
0
reviews
7
references
2
suppliers
10 reagents managed
ELISA
FACS
IHC
IF
RIA
WB
Antigen/Gene or Protein Targets: Activating Protein 2 (AP-2) alpha and beta forms.
0
reviews
6
references
4
suppliers
FACS
IHC
IF
IP
WB
Antigen/Gene or Protein Targets: ErbB4 (Her4, p180erbB4)
0
reviews
10
references
4
suppliers
ChIP
IHC
WB
Antigen/Gene or Protein Targets: Activating Protein 2 (AP-2) alpha (Human)
0
reviews
5
references
5
suppliers
IHC
IP
WB
Antigen/Gene or Protein Targets: Activating Protein 2 (AP-2) gamma
0
reviews
4
references
3
suppliers
ELISA
IHC
WB
Antigen/Gene or Protein Targets: Activating Protein 2 (AP-2) beta
0
reviews
3
references
2
suppliers
ELISA
IP
WB
Antigen/Gene or Protein Targets: Activating Protein 2 (AP-2) beta (Human)
0
reviews
Add a reference
2
suppliers
IHC
IF
IP
WB
Antigen/Gene or Protein Targets: SV40 small T antigen
0
reviews
6
references
3
suppliers
![Western blotting on an array of lysates prepared from cultured cells using anti-RIP140 [6D7]. Antibody dilution: 1/500, incubated o/n in PBS+NaN3. Secondary: anti-mouse HRP, 1/2000, 1h. Exposure: 1min](https://res.cloudinary.com/ximbio/image/upload/c_thumb,h_124,r_max,w_124/f1234c16-ce81-4f83-97be-1233395de777.jpg)
RECENTLY UPDATED
Anti-p53 [PAb242]
Invented by David Lane at Cancer Research UK London Research Institute: Clare Hall Laboratories
